GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » YoY Rev. per Sh. Growth

Australian Clinical Labs (ASX:ACL) YoY Rev. per Sh. Growth : -8.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Australian Clinical Labs's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -8.00%.

Australian Clinical Labs's Revenue per Share for the six months ended in Dec. 2023 was A$1.68.

Australian Clinical Labs YoY Rev. per Sh. Growth Historical Data

The historical data trend for Australian Clinical Labs's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs YoY Rev. per Sh. Growth Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
YoY Rev. per Sh. Growth
- - 16.46 -29.92

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - -31.91 -27.51 -8.00

Australian Clinical Labs YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Australian Clinical Labs's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(3.441-4.91)/ | 4.91 |
=-29.92 %

Australian Clinical Labs's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(1.678-1.824)/ | 1.824 |
=-8.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australian Clinical Labs YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ASX:MVF ASX:IDX ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:HLS ASX:LDX ASX:CTE ASX:GTG TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Website
https://www.clinicallabs.com.au
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines